Rachel K Yost

Title: Rachel K Yost: Innovator in Cell Therapy

Introduction

Rachel K Yost is a prominent inventor based in Seattle, WA (US), known for her significant contributions to the field of cell therapy. With a total of 5 patents, she has made remarkable advancements that enhance therapeutic approaches in treating various diseases.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Phenotypic markers for cell therapy and related methods." This patent provides methods, compositions, and articles of manufacture for use in cell therapy, particularly involving the administration of therapeutic T cell compositions. The T cell compositions express recombinant receptors, including chimeric antigen receptors (CARs) and other transgenic receptors. The features of this invention offer advantages such as consistent dosing, reduced toxicity risk, and improved responses in treated subjects. Another notable patent is focused on "Articles of manufacture and methods for treatment using adoptive cell therapy." This patent outlines methods for administering doses of cells to treat diseases, including certain B cell malignancies, and emphasizes the use of CARs in the therapeutic process.

Career Highlights

Rachel K Yost is currently associated with Juno Therapeutics GmbH, where she continues to innovate in the field of cell therapy. Her work has been instrumental in developing new therapeutic strategies that leverage the power of engineered T cells to combat various malignancies.

Collaborations

Rachel collaborates with esteemed colleagues, including Brian Christin and Christopher Glen Ramsborg, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Rachel K Yost's contributions to cell therapy through her patents and work at Juno Therapeutics GmbH highlight her as a leading figure in the field. Her innovative approaches are paving the way for more effective treatments for patients with challenging diseases.